Hydrofarm Holdings Group reported a significant decline in net sales to $14.5 million for the third quarter of 2026 compared to $29.4 million in the prior year, driven by industry oversupply and customer pricing pressures. The company recorded a net loss for the nine-month period of $33.0 million and reported a total stockholders' deficit of $93.9 million, raising concerns about its ability to continue as a going concern.
Traws Pharma reported Q3 2026 financial results and provided clinical updates for its COVID-19 and influenza antiviral programs. The company highlighted positive Phase 2a results for ratutrelvir and plans to engage the FDA on a registration strategy for PAXLOVID-ineligible patients.
Term
Q3 2026
“We have made meaningful progress toward our goal of developing new treatment and prevention options for patients most vulnerable to serious respiratory viral diseases.”
Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma
“For tivoxavir marboxil, the tablet bridging study achieved its objectives, and toxicology retesting is complete. These results support further evaluation of TXM as a potential once-monthly oral influenza prevention option. We expect to resubmit the updated toxicology package in the fourth quarter.”
Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma
Bridger Aerospace Group Holdings Financial Results
Bridger Aerospace reported third quarter 2026 revenue of $56.7 million, a 13% increase compared to the prior year period. The company announced a strategic review of alternatives to refocus on core aerial services and high-margin business lines. Additionally, the company reported a net loss of $1.8 million for the quarter, an improvement from a $13.4 million net loss in Q3 2025.
Toppoint Holdings reported Q3 2026 revenue of $4.5 million and a net loss of $0.09 million, a significant improvement from the $4.15 million loss in the prior-year period. The company also announced a one-for-five reverse stock split effective November 23, 2026, following a trading halt by NYSE American due to low share price.
AMC Robotics reported Q3 2026 revenue of $0.97 million, a 3.1% sequential increase driven by product sales growth. The company is prioritizing its Kyro quadruped robotic platform for security and inspection markets while remaining on track to commission its Vietnam manufacturing facility by year-end 2026.
Term
Q3 2026
“During the quarter, we sharpened our strategic focus on advancing Kyro, our quadruped robotic platform, toward commercialization, prioritizing opportunities in security, surveillance and inspection markets.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
“The appointment of Dr. Ang Li as Chief Technology Officer further strengthens our ability to accelerate product development and bring more advanced autonomous capabilities to market, while continued progress at our Vietnam manufacturing facility keeps us on track towards initial trial production in early 2027.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
Sadot Group Inc. reported a significant turnaround for the nine months ended September 30, 2026, with a net income of $32.2 million compared to a net loss of $14.2 million in the prior year, primarily driven by a $42.4 million gain on deconsolidation. Despite this, the company experienced a net loss of $3.0 million for the third quarter of 2026 as commodity sales fell sharply compared to the prior year's nine-month volume.
NRX Pharmaceuticals reported a net loss of $20.1 million for the nine months ended September 30, 2026, an improvement from the $29.0 million loss in the prior year period. The company significantly increased its cash position to $19.8 million through various equity offerings, while net patient service revenue grew to $3.3 million.
BrainStorm Cell Therapeutics reported a net loss of $7.7 million for the nine months ended September 30, 2026, compared to $7.9 million in the prior year period. The company faces a significant stockholders' deficit of $12.3 million and maintains a very low cash position of $163 thousand, relying on private placements and short-term loans to fund operations.
MediaCo Holding Inc. reported a net loss of $9.3 million for the third quarter of 2026, compared to a $17.9 million loss in the prior year period. Net revenues decreased to $28.6 million from $35.4 million year-over-year, while the company's total liabilities increased slightly to $249.1 million as of September 30, 2026.
Swarmer, Inc. reported a significant increase in net loss to $21.1 million for the nine months ended September 30, 2026, compared to $5.7 million in the prior year, primarily driven by a surge in operating expenses following its initial public offering. Despite the loss, the company strengthened its liquidity position, ending the period with $37.3 million in cash and cash equivalents.
Okmin Resources reported a net loss of $122,493 for the quarter ended September 30, 2026, compared to a loss of $73,430 in the prior year period. The company's financial position remains strained with a working capital deficit of $776,920 and a significant impairment charge of $53,872 taken on its oil and gas properties during the quarter.
Iron Dome Acquisition I Corp. reported net income of $1,087,694 for the quarter ended September 30, 2026, primarily driven by $1,408,474 in interest income from its Trust Account. As a shell company, its primary activities involved completing its initial public offering and managing $159,850,245 in cash held in trust for a future business combination.
AgEagle Aerial Systems reported a significant decline in nine-month revenue from $9.82 million in 2025 to $5.97 million in 2026, alongside a net loss of $21.78 million. The company's cash position decreased from $29.86 million at year-end 2025 to $10.16 million as of September 30, 2026, driven by increased operating expenses and unrealized losses on investments.
Target Group Inc. reported a significant revenue increase to $4.27 million for the nine months ended September 30, 2026, compared to $3.15 million in the prior year. Despite higher gross profits, the company realized a net loss of $958,449 for the period, contributing to a total stockholders' deficiency of $8.83 million.
KRAKacquisition Corp reported a net loss of $3,020,297 for the nine months ended September 30, 2026, primarily driven by $11.36 million in general and administrative expenses. As a blank check company, it successfully completed its Initial Public Offering in January 2026, resulting in $352,953,916 held in a Trust Account for a future business combination.
For the nine months ended September 30, 2026, 20/20 Biolabs, Inc. reported a net loss of $5.06 million on revenues of $1.46 million, compared to a net loss of $2.43 million on revenues of $1.51 million in the prior year period. The company experienced a significant increase in operating expenses, primarily driven by sales, general, and administrative costs, and underwent a major capital restructuring involving the conversion of multiple preferred stock series into common stock.
Creative Media & Community Trust Corp reported a net loss attributable to common stockholders of $64.8 million for the nine months ended September 30, 2026, compared to a $43.9 million loss in the prior year period. The company experienced significant non-cash charges, including a $7.97 million real estate impairment and $22.4 million in preferred stock redemptions, while total revenues slightly decreased to $86.5 million.
Marker Therapeutics, Inc. reported financial results for the quarter ended September 30, 2026, highlighting continued progress in its clinical-stage cell therapy pipeline. The company maintained a net loss as it invests in R&D, with sufficient cash reserves to support operations into the following year.
For the nine months ended September 30, 2026, Beacon Topco reported a net loss of $22.2 million, a significant reduction from the $55.4 million loss in the prior year period. The company maintained a cash position of $49.2 million and plans to rename itself Clywedog Therapeutics Holdings, Inc. following a pending merger transaction.
Maui Land & Pineapple Co Inc reported a net loss of $1.14 million for the third quarter of 2026, compared to a net income of $240,000 in the same period of 2025. Total operating revenues decreased to $3.84 million from $4.53 million, primarily driven by a significant decline in land development and sales revenue.
For the nine months ended September 30, 2026, Vaso Corp reported total revenues of $31.8 million and net income of $1.3 million, an increase from $439,000 in the prior year period. The company's financial position was significantly impacted by the divestiture of NetWolves, resulting in a $3.5 million gain and a substantial increase in cash and cash equivalents to $49.9 million.
Wrap Technologies reported Q3 2026 revenue of $1.5 million, consistent with the prior year, while nine-month revenue grew 43% to $4.7 million. The company also announced the appointment of Eric Bowen as Chief Operating Officer, effective November 16, 2026, with a compensation package including a $200,000 base salary and 250,000 stock options.
Maui Land & Pineapple Company reported financial results for the third quarter of 2026, highlighting $10.2 million in recurring revenue from its core leasing businesses year-to-date. The company also announced over $20 million of land sales currently in escrow and the formation of a new agave distilling joint venture with Ocean Vodka.
Term
Q3 2026
“Our strategy is to operate our core income-producing assets well, build new businesses on land we already own, and recycle capital out of assets that are no longer core to our mission.”
Race Randle, CEO of Maui Land & Pineapple Company, Inc.
“This year, our commercial and land leasing businesses continued to provide a stable foundation, we have more than $20 million of land sales in escrow, and we formed Maui Agave Ventures with Ocean Vodka as the next step in our commitment to value-added agriculture.”
Race Randle, CEO of Maui Land & Pineapple Company, Inc.
20/20 Biolabs reported its Q3 2026 financial results, highlighted by a 4.1% increase in OneTest revenue to $1.36 million for the first nine months of the year and a gross margin expansion to 32.8%. The company ended the quarter with $3.63 million in cash and no debt, while securing a new two-year firefighter cancer screening contract with the state of Vermont expected to contribute to revenue in Q4.
Term
Q3 2026
“OneTest™ revenue grew 4.1% through the first nine months of the year, with gross profit increasing 15.6%. While third quarter revenue was below the prior year, much of this reflected the timing of our state-funded firefighter cancer screening programs. Maryland completed a significant portion of its testing in the second quarter, while the start of Vermont’s program shifted into the fourth quarter. Vermont has now executed its two-year contract, and we expect testing to begin contributing to revenue before year-end.”
Jonathan Cohen, President and Chief Executive Officer
“We ended the third quarter with $3.63 million in cash and no outstanding borrowings, compared to $1.03 million in cash at year-end 2025. Our net loss narrowed to $1.38 million from $1.51 million in the second quarter, while operating expenses declined 4.0% sequentially.”
Quantum X, Inc. (formerly Two Hands Corporation) reported a net loss of $2,927,672 for the nine months ended September 30, 2026, as it shifts its focus toward AI and quantum computing. The company's balance sheet shows a significant stockholders' deficit of $2,631,455 and a reliance on related-party notes to fund its transition and operating expenses.
PowerCompute, Inc. reported a net loss of $14.3 million for the nine months ended September 30, 2026, compared to a $9.1 million loss in the prior year period. While digital mining revenues decreased slightly, the company experienced significant volatility in the fair value of Bitcoin and recognized a $2.7 million loss on loan derivatives.
Alaunos Therapeutics reported a net loss of $2.7 million for the nine months ended September 30, 2026, as it transitioned from TCR therapies to pulmonary arterial hypertension treatments. The company's cash position decreased to $615,000, and it recently acquired Velaris Therapeutics in October 2026 to bolster its pipeline.
Future FinTech Group Inc. reported a net loss of $4.2 million for the nine months ended September 30, 2026, a significant improvement from the $30.9 million loss from continuing operations in the prior year. Total assets increased to $84.6 million, primarily driven by a $36.3 million increase in other non-current assets and $30 million in proceeds from common stock issuances.
REGO Payment Architectures reported a net loss of $6.8 million for the nine months ended September 30, 2026, compared to a $7.3 million loss in the prior year period. The company generated its first revenues of $64,150 during this period but continues to face a significant stockholders' deficit of $55.8 million and substantial current liabilities.
Exascale Labs Holdings Inc. completed a reverse recapitalization in August 2026, resulting in a significant increase in cash to $12.8 million and the conversion of $40 million in SAFEs into equity. For the quarter ended September 30, 2026, the company reported revenues of $4.3 million but incurred a net loss of $11.4 million, primarily driven by a $9.9 million non-cash charge related to the change in fair value of SAFEs.